Fresenius Medical Care AG
FME: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| ^L | LOCK|N@&yP | LOCK|#pk^cKc |
Fresenius Medical Care Earnings: Solid Trends Put It on Target to Meet 2025 Expectations
In constant currency in the second quarter, Fresenius Medical Care generated 7% organic revenue growth, adjusted operating income growth of 13%, and adjusted EPS growth of 30% including lower interest, tax, and minority interest expenses. Management also confirmed their guidance for 2025.
